China Life Insurance (HKG:2628) Third Quarter 2024 Results
Key Financial Results
- Revenue: CN¥115.9b (up 69% from 3Q 2023).
- Net income: CN¥66.2b (up by CN¥62.7b from 3Q 2023).
- Profit margin: 57% (up from 5.2% in 3Q 2023).
- EPS: CN¥2.35 (up from CN¥0.13 in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
China Life Insurance Earnings Insights
Looking ahead, revenue is expected to decline by 3.1% p.a. on average during the next 3 years, while revenues in the Insurance industry in Hong Kong are expected to grow by 2.7%.
Performance of the Hong Kong Insurance industry.
The company's shares are down 2.4% from a week ago.
Risk Analysis
It's necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with China Life Insurance (at least 1 which is concerning), and understanding these should be part of your investment process.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.